Prospective study of sentinel lymph node biopsy for conjunctival melanoma

British Journal of Ophthalmology

Volumn 97, Issue 12, 2013, Pages 1525-1529

  Cohen, Victoria M L ^a   Tsimpida, Maria ^a   Hungerford, John L ^a   Jan, Hikmat ^b   Cerio, Rino ^b   Moir, Graeme ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; STRONTIUM 90; TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHILD; CONJUNCTIVA DISEASE; CONJUNCTIVAL MELANOMA; CRYOTHERAPY; ELECTRON THERAPY; FACIAL NERVE PARALYSIS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MICROMETASTASIS; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; TUMOR LOCALIZATION; TUMOR VOLUME;

CONJUNCTIVA; NEOPLASIA;

ADOLESCENT; ADULT; AGED; CHILD; CONJUNCTIVAL NEOPLASMS; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MELANOMA; METHYLENE BLUE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM; YOUNG ADULT;

EID: 84888642061     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303671     Document Type: Article

References (25)

1. Triay E, Bergman L, Nilsson B, et al. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol 2009;93:1524-8.
2. Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998;42:321-50. (Pubitemid 28092772)
3. Shields CL, Shields JA, Gündüz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000;118:1497-507.
4. Brownstein S. Malignant melanoma of the conjunctiva. Cancer Control 2004;11:310-16. (Pubitemid 40310586)
5. Esmaeli B, Wang X, Youssef A, et al. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology 2001;108:2101-5. (Pubitemid 33032786)
6. Tuomaala S, Eskelin S, Tarkkanen A, et al. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 2002;43:3399-408. (Pubitemid 35334346)
7. Paridaens AD, Minassian DC, McCartney AC, et al. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 1994;78:252-9. (Pubitemid 24114163)
8. Missotten GS, Keijser S, De Keizer RJW, et al. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 2005;46:75-82. (Pubitemid 40041181)
9. Shields CL, Markowitz JS, Belinsky I, et al. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology 2011;118:389-95 e1-2.
10. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 2002;25:248-55. (Pubitemid 34602545)
11. Cohen VML, Ahmadi-lari S, Hungerford JL. Gastric metastases from conjunctival melanoma. Melanoma Res 2007;17:255-6. (Pubitemid 47067085)
12. De Potter P, Shields CL, Shields JA, et al. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol 1993;77:624-30. (Pubitemid 23298381)
13. Esmaeli B, Eicher S, Popp J, et al. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg 2001;17:436-42. (Pubitemid 33116896)
14. Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol 2002;13:317-23.
15. Amato M, Esmaeli B, Ahmadi MA, et al. Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies. Ophthal Plast Reconstr Surg 2003;19:102-6. (Pubitemid 36348962)
16. Nijhawan N, Ross MI, Diba R, et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg 2004;20:291-5. (Pubitemid 38971783)
17. Ho VH, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 2007;133:820-6. (Pubitemid 47295766)
18. Savar A, Ross MI, Prieto VG, et al. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 2009;116:2217-23.
19. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000;118:1497-507.
20. Missotten GS, Keijser S, De Keizer RJ, et al. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 2005;46:75-82. (Pubitemid 40041181)
21. Wilson MW, Fleming JC, Fleming RM, et al. Sentinel node biopsy for orbital and ocular adnexal tumors. Ophthal Plast Reconstr Surg 2001;17:338-44; discussion 44-45-44; discussion 44-45.
22. Bilchik AJ, Giuliano A, Essner R, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 1998;4:351-8.
23. Sherman DD, Gonnering RS, Wallow IH, et al. Identification of orbital lymphatics: enzyme histochemical light microscopic and electron microscopic studies. Ophthal Plast Reconstr Surg 1993;9:153-69. (Pubitemid 23260814)
24. Gomez-Rivera F, Santillan A, McMurphey AB, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck 2008;30:1284-94.
25. Pfeiffer ML, Savar A, Esmaeli B. Sentinel lymph node biopsy for eyelid and conjunctival tumors: what have we learned in the past decade? Ophthal Plast Reconstr Surg 2013;29:57-62.